Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy

American Journal of Veterinary Research

Volumn 73, Issue 2, 2012, Pages 202-212

  Riesen, Sabine C ^a,b   Schober, Karsten E ^a   Smith, Danielle N ^a   Otoni, Cristiane C ^a,c   Li, Xiaobai ^a   Bonagura, John D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; ESMOLOL; IVABRADINE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR PARAMETERS; CHRONOTROPISM; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; EXPERIMENTAL DOG; FEMALE; FRACTIONAL AREA CHANGE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART RATE; HYPERTROPHIC CARDIOMYOPATHY; ISOVOLUMIC RELAXATION TIME; LOADING DRUG DOSE; MALE; NONHUMAN; PULMONARY ARTERY; SINGLE DRUG DOSE; SYSTOLE;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; BENZAZEPINES; BLOOD PRESSURE; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOVASCULAR AGENTS; CAT DISEASES; CATS; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; PROPANOLAMINES; VENTRICULAR FUNCTION, LEFT;

ANIMALIA;

EID: 84863016466     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.2.202     Document Type: Article

References (50)

1. Atkins CE, Gallo AM, Kurzman ID, et al. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc 1992;201:613-618.
2. Liu SK, Roberts WC, Maron BJ. Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs. Am J Cardiol 1993;72:944-951.
3. Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 2002;220:202-207.
4. Bright JM, Golden AL. Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats. Vet Clin North Am Small Anim Pract 1991;21:1023-1034.
5. Bright JM, Golden AL, Gompf RE, et al. Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy. J Vet Intern Med 1991;5:272-282.
6. Fox PR. Evidence for or against efficacy of beta-blockers and aspirin for management of feline cardiomyopathies. Vet Clin North Am Small Anim Pract 1991;21:1011-1022.
7. Wall M, Calvert CA, Sanderson SL, et al. Evaluation of extended- release diltiazem once daily for cats with hypertrophic cardiomyopathy. J Am Anim Hosp Assoc 2005;41:98.
8. Watson AD, Church DB. Preferences of veterinarians for drugs to treat heart disease in dogs and cats. Aust Vet J 1995;72:401-403.
9. Schober KE, Maerz I. Assessment of left atrial appendage flow velocity and its relation to spontaneous echocardiographic contrast in 89 cats with myocardial disease. J Vet Intern Med 2006;20:120-130.
10. Colin P, Ghaleh B, Monnet X, et al. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 2004;308:236-240.
11. Dilsizian V, Bonow RO, Epstein SE, et al. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:796-804.
12. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004;64:1757-1765.
13. Manz M, Reuter M, Lauck G, et al. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology 2003;100:149-155.
14. Tardif JC. Heart rate as a treatable cardiovascular risk factor. Br Med Bull 2009;90:71-84.
15. Vilaine JP. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Pharmacol Res 2006;53:424-434.
16. Wahl-Schott C, Biel M. HCN channels: structure, cellular regulation and physiological function. Cell Mol Life Sci 2009;66:470-494.
17. Bucchi A, Barbuti A, Baruscotti M, et al. Heart rate reduction via selective 'funny' channel blockers. Curr Opin Pharmacol 2007;7:208-213.
18. Ferasin L. Feline myocardial disease. 1: classification, pathophysiology and clinical presentation. J Feline Med Surg 2009;11:3-13.
19. Fox PR. Hypertrophic cardiomyopathy. Clinical and pathologic correlates. J Vet Cardiol 2003;5:39-45.
20. Schober KE, Fuentes VL, Bonagura JD. Comparison between invasive hemodynamic measurements and noninvasive assessment of left ventricular diastolic function by use of Doppler echocardiography in healthy anesthetized cats. Am J Vet Res 2003;64:93-103.
21. Schober KE, Maerz I. Doppler echocardiographic assessment of left atrial appendage flow velocities in normal cats. J Vet Cardiol 2005;7:15-25.
22. Schober KE, Maerz I. Assessment of left atrial appendage flow velocity and its relation to spontaneous echocardiographic contrast in 89 cats with myocardial disease. J Vet Intern Med 2006;20:120-130.
23. Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993;7:247-252.
24. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
25. Koffas H, Dukes-McEwan J, Corcoran BM, et al. Pulsed tissue Doppler imaging in normal cats and cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006;20:65-77.
26. Chetboul V, Serres F, Gouni V, et al. Radial strain and strain rate by two-dimensional speckle tracking echocardiography and the tissue velocity based technique in the dog. J Vet Cardiol 2007;9:69-81.
27. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976;58:751-760.
28. Colin P, Ghaleh B, Monnet X, et al. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 2003;284:H676-H682.
29. Wilkinson PL, Tyberg JV, Moyers JR, et al. Correlates of myocardial oxygen consumption when afterload changes during halothane anesthesia in dogs. Anesth Analg 1980;59:233-239.
30. Gardner RC, Neufeld RWJ. Use of the simple change score in correlation analyses. Educ Psychol Meas 1987;47:849-864.
31. Thollon C, Bidouard JP, Cambarrat C, et al. Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257. Eur J Pharmacol 1997;339:43-51.
32. Simon L, Ghaleh B, Puybasset L, et al. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995;275:659-666.
33. Monnet X, Ghaleh B, Colin P, et al. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning. J Pharmacol Exp Ther 2001;299:1133-1139.
34. Colin P, Ghaleh B, Hittinger L, et al. Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise. Am J Physiol Heart Circ Physiol 2002;282:H672-H679.
35. Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D 2003;4:83-89.
36. Borer JS, Fox K, Jaillon P, et al. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107:817-823.
37. Tilley LP, Weitz J. Pharmacologic and other forms of medical therapy in feline cardiac disease. Vet Clin North Am Small Anim Pract 1977;7:415-428.
38. Moore PG, Reitan JA, Kien ND, et al. Role of systemic arterial pressure, heart rate, and derived variables in prediction of severity of myocardial ischemia during acute coronary occlusion in anesthetized dogs. Anesth Analg 1992;75:336-344.
39. Rouleau JR, Simard D, Kingma JG Jr. Myocardial blood flow regulation relative to left ventricle pressure and volume in anesthetized dogs. Can J Physiol Pharmacol 1999;77:902-908.
40. Shaddy RE, Tyndall M, Teitel D, et al. The effects of changes in heart rate and aortic systolic pressure on left ventricular myocardial oxygen consumption in lambs. J Dev Physiol 1989;11:213.
41. Toorop GP, Hardjowijono R, Dalinghaus M, et al. Myocardial blood flow and Vo2 in conscious lambs with an aortopulmonary shunt. Am J Physiol 1987;252:H681-H686.
42. Hittinger L, Shannon RP, Bishop SP, et al. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 1989;65:971-980.
43. Constable P, Muir W, Sisson D. Clinical assessment of left ventricular relaxation. J Vet Intern Med 1999;13:5-13.
44. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res 1981;48:813-824.
45. Blaustein AS, Gaasch WH. Myocardial relaxation. VI. Effects of beta-adrenergic tone and asynchrony on LV relaxation rate. Am J Physiol 1983;244:H417-H422.
46. Glantz SA, Parmley WW. Factors which affect the diastolic pressure- volume curve. Circ Res 1978;42:171-180.
47. Frederiksen JW, Weiss JL, Weisfeldt ML. Time constant of isovolumic pressure fall: determinants in the working left ventricle. Am J Physiol 1978;235:H701-H706.
48. Schober KE, Bonagura JD, Scansen BA, et al. Estimation of left ventricular filling pressure by use of Doppler echocardiography in healthy anesthetized dogs subjected to acute volume loading. Am J Vet Res 2008;69:1034-1049.
49. Paulus WJ, Bronzwaer JG, Felice H, et al. Deficient acceleration of left ventricular relaxation during exercise after heart transplantation. Circulation 1992;86:1175-1185.
50. Hoit BD, Shao Y, Gabel M, et al. In vivo assessment of left atrial contractile performance in normal and pathological conditions using a time-varying elastance model. Circulation 1994;89:1829-1838.